To hear about similar clinical trials, please enter your email below
Trial Title:
Insights Into Participating in Studies for Uterine Cancer
NCT ID:
NCT05998811
Condition:
Uterine Cancer
Conditions: Official terms:
Uterine Neoplasms
Conditions: Keywords:
Uterine Cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical study participation has historically been heavily biased toward specific
demographics.
Several people will be invited to enroll in this trial so that it may collect a variety
of data about uterine cancer clinical study experiences and identify barriers to
participation as well as the causes of participants' failure or withdrawal.
People with uterine cancer who are invited to take part in medical study will benefit
from the analysis of the data.
Criteria for eligibility:
Study pop:
Uterine cancer patients who are actively considering enrolling in a clinical trial for
the said condition, but have not yet completed enrollment and randomization phases.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Diagnosis of uterine cancer
- No prior treatment for uterine cancer
Exclusion Criteria:
- Has known psychiatric or substance abuse disorders that would interfere with
cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
September 2024
Completion date:
September 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05998811
